MedPath

Stereophotogrammetry of the Torso in Healthy Individuals and Patients With Scoliosis, Chest Wall Deformations, or Obesity

Completed
Conditions
Obesity
Healthy Volunteers
Bone Diseases
Registration Number
NCT01352949
Lead Sponsor
National Institutes of Health Clinical Center (CC)
Brief Summary

Background:

- Stereophotogrammetry (SP) uses four sets of digital cameras to generate a three-dimensional computer image. Unlike other types of evaluations which require radiation, SP only uses computer images to learn more about physical deformities such as scoliosis or about the placement of fat on the body. To refine the SP process, researchers are interested in collecting images and body data from individuals with skeletal structural problems such as scoliosis or chest wall deformities, individuals who are overweight or obese, and healthy volunteers.

Objectives:

- To use stereophotogrammetry to study different individual body types and refine existing imaging techniques.

Eligibility:

- Individuals at least 2 years of age who have spine, rib, or chest wall deformities; are overweight or obese (body mass index greater than 25); or are healthy volunteers.

Design:

* Participants will be screened with a physical examination and medical history. The physical examination will include measurements of range of motion and joint mobility, torso width and length, and other observational data.

* Healthy volunteers and participants in the obesity group will also have bioelectric spectroscopy (bioimpedance), which uses an additional machine to measure how fat is spread in different parts of the body.

* After the physical examination has been completed, participants will have SP photographs taken. Participants will be asked to remove all clothing from the torso, stand with arms raised at the center of four cameras, and remain still while several images are taken. A complete image takes less than 1 second.

* Participants with spine or rib deformities, or who are in the obesity group, may also volunteer to return for followup SP imaging, once a year for 5 years, to study progress over time.

Detailed Description

Objective

The primary objective of this project is to determine which outcome measures derived from analysis of SP images are reliable within the healthy population and can distinguish between healthy volunteers and those with scoliosis, chest wall deformities, and obesity. Secondary objectives include comparing SP outcome measures with clinical and radiographic measures to test concurrent validity and to determine if the SP outcome measures correlate with clinical and radiographic measures taken over time. The ultimate goal is to develop SP as a measurement tool to be employed in clinical research involving the study of scoliosis, rib and chest deformities and the truncal distribution of adiposity.

Study population

The population for this study consists of healthy volunteers, persons with scoliosis and/or chest wall deformities, and persons with obesity. Men and women of all races, ethnicities, and ages greater than two years may participate.

Design

This project will be carried out in three phases. In Phase I, we will analyze images of healthy volunteers captured by the SP scoliosis and chest-wall deformity ( scoliosis ) software to identify the outcome measures that show minimal or no variance. We will also examine if healthy volunteers gender, age, height, and BMI contribute to the differences of these outcome measures.

In Phase IIa, images captured from subjects with scoliosis and/or chest wall deformities will be processed by scoliosis software to determine the set of meaningful variables (those that show significant differences between the two populations). In Phase IIb, images captured of healthy volunteers will be processed using obesity software to determine the set of variables showing minimal or no variance among the data from healthy volunteers when controlling for the effects of potential confounders. Variables that continue to have minimal or no variance will be considered meaningful with respect to obesity analysis software. Those variables achieved from obesity image analysis will be compared to the set from the healthy volunteers to determine which variables show significant differences between the healthy volunteer and obese subjects.

In Phase III, healthy participants, scoliosis/chest wall deformity, and obesity participants who are scheduled to return to NIH as part of another NIH protocol will be invited to return for yearly re-imaging up to a total of five years in order to analyze changes over time and compare them with concurrent radiographic measures.

Outcome measures

The purpose of the study is to develop outcome measures for use in future research. These outcome measures will be developed from software which analyzes images derived from the stereophotogrammetry system.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
199
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Output variables provided by the Matlab stereophotogrammetry analysis programafter accrual of 50 subjects, 100 subjects, and all subjects

Measures derived from mathematical analysis of cross sections of the 3d torso computer model

Other variables calculated from the Matlab stereophotogrammetry output variablesafter accrual of 50 subjects, 100 subjects, and all subjects

Variables calculated by comparing and connecting the outputs of individual cross sectional analyses described above.

Secondary Outcome Measures
NameTimeMethod
stand and reachafter accrual of 50 subjects, 100 subjects, and all subjects

physical parameters which will be measured in order to perform tests of concurrent validity for obesity

chest circumferenceafter accrual of 50 subjects, 100 subjects, and all subjects

physical parameters which will be measured in order to perform tests of concurrent validity for scoliosis/chest-wall deformities

rib symmetryafter accrual of 50 subjects, 100 subjects, and all subjects

physical parameters which will be measured in order to perform tests of concurrent validity for scoliosis/chest-wall deformities

WHRafter accrual of 50 subjects, 100 subjects, and all subjects

physical parameters which will be measured in order to perform tests of concurrent validity for obesity

leg length discrepanciesafter accrual of 50 subjects, 100 subjects, and all subjects

physical parameters which will be measured in order to perform tests of concurrent validity for scoliosis/chest-wall deformities

pectus carinatumafter accrual of 50 subjects, 100 subjects, and all subjects

physical parameters which will be measured in order to perform tests of concurrent validity for scoliosis/chest-wall deformities

pectus excavatumafter accrual of 50 subjects, 100 subjects, and all subjects

physical parameters which will be measured in order to perform tests of concurrent validity for scoliosis/chest-wall deformities

BMIafter accrual of 50 subjects, 100 subjects, and all subjects

physical parameters which will be measured in order to perform tests of concurrent validity for obesity

pelvic obliquityafter accrual of 50 subjects, 100 subjects, and all subjects

physical parameters which will be measured in order to perform tests of concurrent validity for scoliosis/chest-wall deformities

AP chest diameterafter accrual of 50 subjects, 100 subjects, and all subjects

physical parameters which will be measured in order to perform tests of concurrent validity for scoliosis/chest-wall deformities

Adam s forward bending testafter accrual of 50 subjects, 100 subjects, and all subjects

physical parameters which will be measured in order to perform tests of concurrent validity for scoliosis/chest-wall deformities

Schober testafter accrual of 50 subjects, 100 subjects, and all subjects

physical parameters which will be measured in order to perform tests of concurrent validity for obesity

finger-floor testafter accrual of 50 subjects, 100 subjects, and all subjects

physical parameters which will be measured in order to perform tests of concurrent validity for obesity

Trial Locations

Locations (1)

National Institutes of Health Clinical Center

🇺🇸

Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath